EA
KPTI icon

Emerald Advisers’s Karyopharm Therapeutics KPTI Stock Holding History

Emerald Advisers’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,098
Closed -$489K – 296
2021
Q1 		$489K Sell
3,098
-118,421
-97% -$25M 0.02% 198
2020
Q4 		$28.2M Buy
121,519
+14,635
+14% +$3.39M 0.94% 37
2020
Q3 		$23.4M Buy
106,884
+23,937
+29% +$5.86M 0.96% 38
2020
Q2 		$23.6M Buy
82,947
+13,244
+19% +$3.92M 1.03% 35
2020
Q1 		$20.1M Buy
69,703
+36,286
+109% +$10M 1.16% 25
2019
Q4 		$9.61M Sell
33,417
-66,355
-67% -$14.4M 0.41% 94
2019
Q3 		$14.4M Buy
99,772
+1,356
+1% +$184K 0.67% 56
2019
Q2 		$8.84M Sell
98,416
-2,124
-2% -$171K 0.36% 100
2019
Q1 		$8.81M Buy
100,540
+3,442
+4% +$382K 0.36% 103
2018
Q4 		$13.6M Buy
97,098
+50,827
+110% +$8.57M 0.67% 58
2018
Q3 		$11.8M Buy
46,271
+8,850
+24% +$2.45M 0.43% 97
2018
Q2 		$9.54M Buy
+37,421
New +$9.26M 0.36% 107

Other funds holding KPTI

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return